Bosun Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$672K Sell
1,910
-90
-5% -$32.1K 0.36% 36
2025
Q4
$655K Sell
2,000
-100
-5% -$31.7K 0.32% 36
2025
Q3
$593K Sell
2,100
-100
-5% -$29K 0.3% 34
2025
Q2
$614K Sell
2,200
-32
-1% -$9.06K 0.18% 120
2025
Q1
$695K Sell
2,232
-45
-2% -$13.3K 0.3% 87
2024
Q4
$593K Hold
2,277
0.26% 111
2024
Q3
$734K Sell
2,277
-15
-0.7% -$4.91K 0.35% 82
2024
Q2
$716K Sell
2,292
-128
-5% -$37.6K 0.42% 62
2024
Q1
$688K Sell
2,420
-34
-1% -$9.95K 0.39% 82
2023
Q4
$707K Buy
2,454
+70
+3% +$19.1K 0.7% 35
2023
Q3
$641K Sell
2,384
-81
-3% -$20.2K 0.69% 39
2023
Q2
$547K Sell
2,465
-10
-0.4% -$2.32K 0.54% 46
2023
Q1
$598K Hold
2,475
0.68% 45
2022
Q4
$650K Sell
2,475
-25
-1% -$6.7K 0.92% 22
2022
Q3
$564K Hold
2,500
0.87% 21
2022
Q2
$608K Hold
2,500
0.84% 26
2022
Q1
$605K Buy
2,500
+600
+32% +$138K 0.64% 29
2021
Q4
$427K Buy
+1,900
New +$401K 0.39% 37

Other funds holding AMGN

Bosun Asset Management's AMGN Position: Q1 2026 in Review

Bosun Asset Management reduced its Amgen (AMGN) stake by 4.5% in Q1 2026, selling an estimated $32.1K and leaving 1,910 shares worth $672K. The position accounts for 0.36% of the portfolio, ranked #36.

Bosun Asset Management first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $734K in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bosun Asset Management held 1,910 shares of Amgen worth $672K as of Q1 2026.
  • Bosun Asset Management sold 90 Amgen shares in Q1 2026, an estimated $32.1K.
  • Amgen made up 0.36% of Bosun Asset Management's portfolio in Q1 2026, its #36 holding.
  • Bosun Asset Management first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Bosun Asset Management's Amgen position peaked at $734K in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bosun Asset Management's 13F filing for Q1 2026, filed 11 May 2026.